Results 31 to 40 of about 476,894 (337)

A logic programming approach to medical errors in imaging [PDF]

, 2011
Background: In 2000, the Institute of Medicine reported alarming data on the scope and impact of medical errors calling the public attention. One solution to this problem is the adoption of adverse event reporting and learning systems that can help to ...
Alves, Victor, Brandão, Paulo, Nelas, Luís, Neves, José, Rodrigues, Susana Isabel Magalhães da Rocha   +4 more
core   +1 more source

Adverse event profiles of solvent-based and nanoparticle albumin-bound paclitaxel formulations using the Food and Drug Administration Adverse Event Reporting System

SAGE Open Medicine, 2019
Objectives: Paclitaxel is a highly effective antitumor agent with notable adverse events, including hypersensitivity reactions, peripheral neuropathy, arthralgia, myalgias, and neutropenia.
Misa Naganuma, Kohei Tahara, Shiori Hasegawa, Akiho Fukuda, Sayaka Sasaoka, Haruna Hatahira, Yumi Motooka, Satoshi Nakao, Ririka Mukai, Kouseki Hirade, Tomoaki Yoshimura, Takeshi Kato, Hirofumi Takeuchi, Mitsuhiro Nakamura   +13 more
doaj   +1 more source

Ontology Modelling for FDA Adverse Event Reporting System [PDF]

, 2016
Ontologies are relevant to a specific knowledge or application domain and it represents a set of concepts and their inter-relationships. Ontological design comprises of ontology development process, the ontology life cycle, the techniques and ...
, Rima Borah, Rajarajeswari S.
core   +2 more sources

Digital Drug Safety Surveillance: Monitoring Pharmaceutical Products in Twitter [PDF]

, 2014
Background: Traditional adverse event (AE) reporting systems have been slow in adapting to online AE reporting from patients, relying instead on gatekeepers, such as clinicians and drug safety groups, to verify each potential event.
Bao, Wenjie, Brownstein, John S., Dasgupta, Nabarun, Filice, Ross, Freifeld, Clark C., Kass-Hout, Taha, Menone, Christopher M.   +6 more
core   +3 more sources

Completeness of adverse drug reactions reports of the Saudi adverse event reporting system

Saudi Medical Journal, 2015
To assess completeness of reports in the Saudi Adverse Event Reporting System (SAERS), which is a part of the Saudi Food and Drug Authority pharmacovigilance system for monitoring the safety of medications.A cross-sectional study was conducted in Riyadh, Saudi Arabia using the reports that were received between December 2009 and June 2012 in the SAERS.
Waad H. Al-Kathiri, Hervé Le Louet, Hisham Aljadhey, Thamir M. Alshammari   +3 more
openaire   +3 more sources

A pharmacovigilance analysis of FDA adverse event reporting system events for romosozumab

Expert Opinion on Drug Safety, 2022
Romosozumab is a novel drug for the treatment of osteoporosis. The adverse reactions of romosozumab still need to be explored. The FDA Adverse Event Reporting System (FAERS) provides an enormous dataset for adverse events (AEs) analysis. AEs registered in FAERS between January 2019 and December 2020 were collected for this study.
Zepeng Chen, Ming Li, Shuzhen Li, Yuxi Li, Junyan Wu, Kaifeng Qiu, Xiaoxia Yu, Lin Huang, Guanghui Chen   +8 more
openaire   +2 more sources

Indication and adverse event profiles of denosumab and zoledronic acid: based on U.S. FDA adverse event reporting system (FAERS)

Frontiers in Pharmacology, 2023
Objective: To investigate adverse events (AEs) associated with denosumab (Dmab) and zoledronic acid (ZA), compare their association strengths, and explore potential applications to provide clinical reference.Methods: We collected data from FAERS from ...
Si Su, Si Su, Liuqing Wu, Guibao Zhou, Lingling Peng, Huanzhe Zhao, Xiao Wang, Xiao Wang, Kuan Li   +8 more
doaj   +1 more source

Adverse events among Ontario home care clients associated with emergency room visit or hospitalization: a retrospective cohort study [PDF]

, 2013
Background: Home care (HC) is a critical component of the ongoing restructuring of healthcare in Canada. It impacts three dimensions of healthcare delivery: primary healthcare, chronic disease management, and aging at home strategies.
Baker, G. Ross, Blais, Régis, Dill, Donna, Doran, Diane M., Droppo, Lisa, Foebel, Andrea Dawn, Gruneir, Andrea, Heckman, George A., Hirdes, John P., Jantzi, Micaela, Lacroix, Hélène, Li, Xiaoqiang, McIsaac, Corrine, Mitchell, Lori, Nahm, Sang-Myong, O'Beirne, Maeve, Poss, Jeffrey W., Qian, Gan, White, Nancy, Yim, Odilia   +19 more
core   +1 more source

Educating Healthcare Professionals in Pharmacovigilance: Global Trends and Korea’s Status [PDF]

, 2020
This narrative review introduces global trends in pharmacovigilance (PV) education for healthcare professionals and the status of PV education in Korea. Proactive participation of healthcare professionals, including physicians, pharmacists, and nurses in
Korean Medical Education Review (의학교육논단)
core   +1 more source

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems

Therapeutics and Clinical Risk Management, 2021
The purpose of this study was to investigate the adverse events (AEs) related to the use of off-label drugs.A cross-sectional study was carried out using available data pertaining to off-label drug were sourced from U.S. FDA spontaneous adverse drug reaction reporting database (FAERS) and Korea Adverse Event Reporting System database (KIDS-KD) for the ...
In-Wha Kim, Nayoung Han, Nayoung Han, Jung Mi Oh   +3 more
openaire   +5 more sources